BFB Health Limited has convened its Annual General Meeting for 30 June 2026, 3:00 p.m., at Portion 2, 12/F, The Center, 99 Queen’s Road Central, Hong Kong. Shareholders will first consider the audited consolidated financial statements for the year ended 31 December 2025, followed by routine matters that include re-electing Executive Directors Li Leong and Wu Mansheng, Independent Non-executive Director Law Chi Hung, approving directors’ remuneration and re-appointing Infinity CPA Limited as external auditor.
Special business centers on capital management authorities: • General Issuance Mandate – Directors seek approval to allot, issue or deal with additional shares up to 20% of the company’s issued share capital (excluding treasury shares) during the defined “Relevant Period.” • Share Repurchase Mandate – Authority is requested to buy back shares on the Stock Exchange up to 10% of issued share capital (excluding treasury shares) within the same period. • Mandate Extension – Shares repurchased under the 10% authority may be added to the 20% issuance limit, effectively expanding potential placement capacity.
The register of members will close from 25 June 2026 to 30 June 2026 inclusive. To qualify for attendance and voting, share transfers must be lodged with Tricor Investor Services Limited by 4:30 p.m. on 24 June 2026. Proxy forms must reach the registrar at least 48 hours before the meeting.
As at the notice date, the board comprises Executive Directors Li Leong, Wu Mansheng, Li Zhen and Zhou Hongtao, together with Independent Non-executive Directors Law Chi Hung, Guo Hui and Fang Ying.
Comments